Stock Taper Q4 Adjusted EPS: $1.23, up 23% year-over-year.
Full Year Adjusted EPS: $4.02, a 13% increase compared to the previous year.
Revenue: $6.4 billion for Q4, driven by synergy realization and disciplined cost management.
Adjusted EBITDA: $1.045 billion for Q4.
Free Cash Flow: $1.3 billion for the fiscal year, impacted by working capital issues related to the Middle East conflict.
Dividend Declared: $0.65 per share, a modest increase from the prior year.
Safety Performance: Total recordable incident rate improved to 0.47, marking four consecutive quarters of improvement.
Synergy Capture: Exceeded expectations with $115 million in Q4, totaling $285 million for the fiscal year, ahead of initial targets.
Portfolio Optimization: Five divestitures completed in H2 FY2026 to focus on higher-growth opportunities.
Volume Growth: Modestly positive volume growth in Q4, with sequential increases across several market categories, particularly in foodservice, pet care, and protein.
Transition Period Guidance: Adjusted EPS expected to be between $1.80 and $1.90 for the six months ending December 31, 2026.
2027 Outlook: Anticipates double-digit adjusted EPS growth, driven by synergy realization and organic volume growth, with leverage expected to be around 3x by year-end 2027.
Working Capital Issues: $500 million impact from the Middle East conflict, with higher-than-expected working capital needs affecting cash flow.
Interest and Tax Expenses: Higher expenses anticipated, which may offset some of the positive earnings growth.
Healthcare Segment Softness: Continued volume declines in lower-margin healthcare categories, although higher-margin segments show promise.
Price/Mix Dynamics: Negative price/mix impact noted, despite successful pass-through of inflation-related costs.
Working Capital Recovery: Management expects to recover $100 million to $200 million of the $500 million working capital impact within the next six months.
Volume Growth Assumptions: Transition period guidance includes flat to modest volume growth, reflecting cautious optimism.
Cost Management: Management remains confident in maintaining pricing power to offset inflation, with a focus on stabilizing costs in the coming quarters.
Synergy Wins: Approximately $140 million in annualized revenue wins achieved, with expectations for gradual revenue conversion over the next 12-24 months. Overall, Amcor demonstrated strong financial performance in Q4 2026, with significant progress on synergies and a positive outlook for 2027, despite facing challenges related to working capital and specific market segments.
SOURCE: Q4 2026 EARNINGS CALL TRANSCRIPT